Correlation Between Regenicin and Tryp Therapeutics

Can any of the company-specific risk be diversified away by investing in both Regenicin and Tryp Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenicin and Tryp Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regenicin and Tryp Therapeutics, you can compare the effects of market volatilities on Regenicin and Tryp Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenicin with a short position of Tryp Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenicin and Tryp Therapeutics.

Diversification Opportunities for Regenicin and Tryp Therapeutics

0.0

Correlation Coefficient

Regenicin  Tryp Therapeutics

Pay attention - limited upside

The 3 months correlation between Regenicin and Tryp is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regenicin and Tryp Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tryp Therapeutics and Regenicin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenicin are associated (or correlated) with Tryp Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tryp Therapeutics has no effect on the direction of Regenicin i.e., Regenicin and Tryp Therapeutics go up and down completely randomly.

Pair Corralation between Regenicin and Tryp Therapeutics

If you would invest (100.00) in Tryp Therapeutics on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Tryp Therapeutics or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Regenicin  vs.  Tryp Therapeutics

Regenicin

Risk-Adjusted Performance

Very Weak

Over the last 90 days Regenicin has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Regenicin is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Tryp Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tryp Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tryp Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Regenicin and Tryp Therapeutics

The main advantage of trading using opposite Regenicin and Tryp Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenicin position performs unexpectedly, Tryp Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tryp Therapeutics will offset losses from the drop in Tryp Therapeutics' long position.

The idea behind Regenicin and Tryp Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.